| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 104.68B | 102.56B | 101.89B | 99.46B | 110.67B | 112.94B |
| Gross Profit | 27.74B | 25.38B | 28.14B | 27.61B | 31.68B | 32.48B |
| EBITDA | 3.34B | 1.73B | 3.62B | 3.47B | 3.65B | 4.39B |
| Net Income | -806.00M | -2.62B | 451.00M | 205.00M | 368.00M | 878.00M |
Balance Sheet | ||||||
| Total Assets | 56.11B | 55.58B | 58.19B | 54.26B | 49.37B | 50.90B |
| Cash, Cash Equivalents and Short-Term Investments | 6.29B | 5.75B | 6.03B | 5.35B | 6.15B | 7.72B |
| Total Debt | 11.38B | 15.31B | 15.58B | 10.42B | 5.29B | 5.48B |
| Total Liabilities | 29.49B | 29.61B | 29.33B | 25.63B | 20.56B | 22.17B |
| Stockholders Equity | 26.62B | 25.97B | 28.86B | 28.63B | 28.81B | 28.73B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.71B | -2.79B | -4.37B | -887.00M | 1.27B |
| Operating Cash Flow | 0.00 | 3.32B | 1.63B | 1.93B | 2.25B | 5.69B |
| Investing Cash Flow | 0.00 | -2.40B | -3.54B | -7.13B | -3.11B | -3.60B |
| Financing Cash Flow | 0.00 | -1.20B | 2.60B | 4.40B | -699.00M | -1.55B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥8.20B | 9.64 | ― | 3.67% | 0.52% | -3.78% | |
74 Outperform | ¥13.88B | 13.08 | ― | 1.49% | 5.86% | -16.20% | |
73 Outperform | ¥11.98B | 7.76 | ― | 2.29% | 10.43% | 12.10% | |
67 Neutral | ¥11.10B | 8.24 | ― | 1.45% | -0.02% | -7.09% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
51 Neutral | ¥12.58B | -15.45 | ― | 2.34% | 2.43% | 50.53% | |
49 Neutral | ¥9.99B | -5.73 | ― | ― | -12.69% | 22.75% |